^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
anti-Claudin 18.2 CAR-T cell therapy
i
Other names: anti-Claudin 18.2 CAR-T cell therapy, LCAR-C182A/LCAR-C182B/LCAR-C182C cells, LB1904, LCAR-C182
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
First Affiliated Hospital Xi'an Jiaotong University, Legend Biotech
Drug class:
CLDN18.2-targeted CAR-T immunotherapy
Related drugs:
